ApiFix Closes Spanish Distribution Deal with Acuna-Fombona

ApiFix ratchet system for scoliosis treatment

The ratchet-based scoliosis treatment system developed by ApiFix has been used on more than 145 patients.

Editor’s note: See this announcement in Spanish.

Following the distribution agreement, ApiFix performed first scoliosis correction surgery in Spain

Medical device company ApiFix, a portfolio company of The Trendlines Group (SGX: 42T; OTCQX: TRNLY), announced it inked an exclusive distribution deal in Spain with Acuña-Fombona, a distributor of Spain and Portugal. The first scoliosis correction surgery was performed in Hospital Universitari Sagrat Cor, Barcelona (Spain)Hospital, Spain by Dr. Juan Carlos Olaverri.

ApiFix has developed a minimally invasive, non-fusion spinal implant system for the correction of Adolescent Idiopathic Scoliosis (AIS). ApiFix improves the quality of life of patients who undergo scoliosis surgery, saves hospitalization and OR time, and costs substantially less than standard scoliosis surgery.

“When Acuña Fombona learned about the ApiFix system, we immediately recognized that the technology is a game-changer for AIS patients. We are thrilled to exclusively represent ApiFix with their non-fusion solution to surgeons and patients alike,” stated Acuña-Fombona CEO, Sergio Fombona.

Acuna Fombona logo

Current scoliosis surgical correction is a highly invasive, lengthy surgical procedure involving fusion, and resulting in a rigid spine with long recovery period. The ApiFix system is a market disruptor with its minimally invasive, non-fusion spinal implant system, inserted in a short procedure, followed by a brief recovery period, and maintains spine flexibility.

ApiFix CEO Eran Feldhay, M.D., remarked: “We are excited to continue our expansion in Europe and to add Spain to the growing list of European countries where we distribute and perform surgeries with the ApiFix system. The Spanish market is important to us and we are proud to offer our products to Spanish AIS patients.”

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize